X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210814
https://www.biospace.com/article/releases/daiichi-sankyo-announces-late-breaking-phase-1-dose-expansion-data-for-patritumab-deruxtecan-in-patients-with-egfr-mutated-nsclc-at-esmo-2020/?s=73
https://www.boehringer-ingelheim.com/press-release/uncommonmutationsdatabase
http://www.pmlive.com/pharma_news/j_and_js_bispecific_lung_cancer_antibody_nabs_fda_breakthrough_status_1328830
http://www.pharmafile.com/news/525736/additional-data-boehringers-giotrif-combo-shows-strong-overall-survival-benefit-lung-can
https://www.fiercepharma.com/pharma/nice-shuts-down-az-s-tagrisso-and-backs-pfizer-rival-vizimpro-instead?utm_source=internal&utm_medium=rss
https://www.raps.org/news-and-articles/news-articles/2018/12/fda-drafts-guidance-on-oncology-companion-diagnost?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%207%20December
https://www.biocentury.com/bc-extra/politics-policy/2018-08-17/china-unveils-cancer-drugs-medical-insurance-access-negotiation
https://www.pharmacompass.com/pdf/news/gilotrif-afatinib-boehringer-ingelheim-et-al-v-apotex-inc-et-al-1530870515.pdf
https://european-biotechnology.com/up-to-date/latest-news/news/afatinib-push-back-k-ras-positive-lung-cancer.html
https://www.pharmacompass.com/pdf/news/gilotrif-afatinib-boehringer-ingelheim-pharmaceuticals-v-fresenius-kabi-usa-1520833213.pdf
https://www.prnewswire.com/news-releases/qiagen-receives-fda-approval-to-expand-use-of-egfr-test-in-lung-cancer-669993403.html
https://www.fiercepharma.com/marketing/boehringer-s-gilotrif-widens-its-reach-crowded-egfr-lung-cancer-field
http://www.pharmatimes.com/news/us_expands_scope_of_bis_lung_cancer_drug_gilotrif_1217213
http://www.prnewswire.com/news-releases/fda-grants-priority-review-to-gilotrif-for-uncommon-egfr-mutations-in-advanced-nsclc-300533422.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-gilotrif-afatinib-dimaleate-tablets-1505366114.pdf
http://www.reuters.com/article/us-health-cancer-pfizer-idUSKBN18W1HD
http://www.prnewswire.com/news-releases/new-analysis-showed-dose-adjustment-of-gilotrif-afatinib-improved-tolerability-without-an-apparent-impact-on-efficacy-in-patients-with-egfr-mutation-positive-non-small-cell-lung-cancer-300323963.html
http://www.fiercepharma.com/pharma-asia/astrazeneca-keeps-double-digit-china-growth-track-q1
http://www.pmlive.com/pharma_news/fda_approves_expanded_indication_for_gilotrif_996892
http://www.prnewswire.com/news-releases/fda-approves-gilotrif-afatinib-as-new-oral-treatment-option-for-patients-with-squamous-cell-carcinoma-of-the-lung-300252403.html
http://www.biospectrumindia.com/biospecindia/news/223413/boehringer-s-gilotrif-gain-ground-nsclc-markets-outside-usa
http://www.prnewswire.com/news-releases/boehringer-ingelheims-gilotrif-afatinib-demonstrated-superiority-to-iressa-gefitinib-in-reducing-the-risk-of-disease-progression-and-treatment-failure-in-first-line-treatment-of-patients-with-egfr-mutation-positive-advanced-300210373.html
http://www.pmlive.com/pharma_news/uk_patients_get_early_access_to_azs_lung_cancer_drug_tagrisso_883737
http://www.pmlive.com/pharma_news/boehringer_takes_third-generation_nsclc_drug_into_pivotal_trials_857039
http://www.pmlive.com/pharma_news/boehringer_teams_up_with_eureka_on_intracellular_cancer_targets_742446
http://www.pharmabiz.com/NewsDetails.aspx?aid=85669&sid=1
Market Place
Share 
